Altitude Crest Partners Inc.
Filing Date
Global Rank
#3,519
/ 7,296
▲ 642
Top Industry
Biotechnology
67.6%
3Y Alpha vs SPY
-24.1%
Period ended 2 years ago
Filed May 14, 2024 · 2y
2 quarters · since Dec 2023
Clone Performance
Feb 2024–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-9.5%
SPY
+52.9%
Annualised alpha
-24.2%
Max drawdown
−45.2%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
23 positions · as of Mar 31, 2024 · Δ vs Dec 31, 2023Top Position
17.5%
−5.9 pts
Top 5
56.2%
−25.5 pts
Top 10
77.2%
−22.8 pts
HHI
837
Diversified−845
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2024| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $208,747,669 |
Last Quarter's Activity
Export CSVNew Positions
Positions the filer opened this quarter
18 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| STVN | Stevanato Group S.p.A. | 550,000 | $17,655,000 | |
| TMO | Thermo Fisher Scientific Inc. | 18,400 | $10,694,264 | |
| AVBP | ArriVent BioPharma, Inc. | 555,555 | $9,922,212 | |
| GPCR | Structure Therapeutics Inc. | 205,166 | $8,793,414 | |
| JANX | Janux Therapeutics, Inc. | 193,300 | $7,277,745 | |
| LLY | ELI LILLY & Co | 9,200 | $7,157,232 | |
| BHVN | Biohaven Ltd. | 118,380 | $6,474,202 | |
| IMNM | Immunome Inc. | 262,284 | $6,473,169 | |
| GERN | Geron Corp | 1,531,400 | $5,053,620 | |
| ICLR | Icon PLC | 14,800 | $4,972,060 | |
| DNLI | Denali Therapeutics Inc. | 209,613 | $4,301,258 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 103,703 | $4,069,305 | |
| AGIO | Agios Pharmaceuticals, Inc. | 113,100 | $3,307,044 | |
| DAWN | Day One Biopharmaceuticals, Inc. | 195,497 | $3,229,610 | |
| ENGN | enGene Therapeutics Inc. | 120,289 | $2,038,898 | |
| ZYME | Zymeworks Inc. | 145,581 | $1,531,512 | |
| MGX | Metagenomi Therapeutics, Inc. | 133,333 | $1,406,663 | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 200 | $29,890 | |
| No positions match the current search. | ||||
23 positions ·
$208,747,669 total
· as of Mar 31, 2024
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| LEGN |
Legend Biotech Corp
Healthcare
|
Added | 652,732 | $36,611,737 | 17.54% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Reduced | 108,700 | $27,144,564 | 13.00% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 612,060 | $18,924,895 | 9.07% | |
| STVN |
Stevanato Group S.p.A.
Healthcare
|
NEW | 550,000 | $17,655,000 | 8.46% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Added | 287,277 | $16,886,142 | 8.09% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
NEW | 18,400 | $10,694,264 | 5.12% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
NEW | 555,555 | $9,922,212 | 4.75% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 205,166 | $8,793,414 | 4.21% | |
| JANX |
Janux Therapeutics, Inc.
Healthcare
|
NEW | 193,300 | $7,277,745 | 3.49% | |
| LLY |
ELI LILLY & Co
Healthcare
|
NEW | 9,200 | $7,157,232 | 3.43% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
NEW | 118,380 | $6,474,202 | 3.10% | |
| IMNM |
Immunome Inc.
Healthcare
|
NEW | 262,284 | $6,473,169 | 3.10% | |
| GERN |
Geron Corp
Healthcare
|
NEW | 1,531,400 | $5,053,620 | 2.42% | |
| ICLR |
Icon PLC
Healthcare
|
NEW | 14,800 | $4,972,060 | 2.38% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 454,766 | $4,793,233 | 2.30% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
NEW | 209,613 | $4,301,258 | 2.06% | |
| CRBP |
Corbus Pharmaceuticals Holdings, Inc.
Healthcare
|
NEW | 103,703 | $4,069,305 | 1.95% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
NEW | 113,100 | $3,307,044 | 1.58% | |
| DAWN |
Day One Biopharmaceuticals, Inc.
Healthcare
|
NEW | 195,497 | $3,229,610 | 1.55% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
NEW | 120,289 | $2,038,898 | 0.98% | |
| ZYME |
Zymeworks Inc.
Healthcare
|
NEW | 145,581 | $1,531,512 | 0.73% | |
| MGX |
Metagenomi Therapeutics, Inc.
Healthcare
|
NEW | 133,333 | $1,406,663 | 0.67% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
NEW | 200 | $29,890 | 0.01% |